Literature DB >> 1606526

The clinical efficacy of IVGG in Kawasaki disease.

A H Rowley1, S T Shulman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1606526     DOI： 10.1007/978-1-4612-0417-6_7

Source DB:  PubMed          Journal:  Clin Rev Allergy        ISSN： 0731-8235


× No keyword cloud information.
  15 in total

Review 1.  Management of Kawasaki syndrome: a consensus statement prepared by North American participants of the Third International Kawasaki Disease Symposium, Tokyo, Japan, December, 1988.

Authors: 
Journal:  Pediatr Infect Dis J       Date:  1989-10       Impact factor: 2.129

2.  Treatment of Kawasaki syndrome.

Authors:  R D Feigin; K S Barron
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

3.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

4.  Treatment of Kawasaki syndrome: a comparison of two dosage regimens of intravenously administered immune globulin.

Authors:  K S Barron; D J Murphy; E D Silverman; H D Ruttenberg; G B Wright; W Franklin; S J Goldberg; S M Higashino; D G Cox; M Lee
Journal:  J Pediatr       Date:  1990-10       Impact factor: 4.406

5.  Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease. Preliminary report.

Authors:  M A Engle; N S Fatica; J B Bussel; J E O'Loughlin; M S Snyder; M L Lesser
Journal:  Am J Dis Child       Date:  1989-11

6.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

Review 7.  Kawasaki syndrome.

Authors:  A H Rowley; F Gonzalez-Crussi; S T Shulman
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

8.  Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy.

Authors:  A H Rowley; C E Duffy; S T Shulman
Journal:  J Pediatr       Date:  1988-08       Impact factor: 4.406

9.  Effect of intravenous immune globulin on the coagulopathy of Kawasaki syndrome.

Authors:  M P Glode; L S Joffe; J Wiggins; S H Clarke; W E Hathaway
Journal:  J Pediatr       Date:  1989-09       Impact factor: 4.406

10.  High-dose intravenous gammaglobulin for Kawasaki disease.

Authors:  K Furusho; T Kamiya; H Nakano; N Kiyosawa; K Shinomiya; T Hayashidera; T Tamura; O Hirose; Y Manabe; T Yokoyama
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321
View more
  2 in total

1.  Atypical Kawasaki disease with peripheral gangrene and myocardial infarction: therapeutic implications.

Authors:  M von Planta; M Fasnacht; C Holm; S Fanconi; R A Seger
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

Review 2.  Intravenous immunoglobulin for the treatment of Kawasaki disease in children.

Authors:  R M Oates-Whitehead; J H Baumer; L Haines; S Love; I K Maconochie; A Gupta; K Roman; J S Dua; I Flynn
Journal:  Cochrane Database Syst Rev       Date:  2003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.